[ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, 26-28 January 2006].
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy; D018572:Disease-Free Survival; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D015994:Incidence; D008495:Medical Oncology; D015201:Meta-Analysis as Topic; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D013274:Stomach Neoplasms / Q000188:drug therapy; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States
D000970:Antineoplastic Agents